Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Food Sci Biotechnol ; 31(10): 1257-1266, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35992322

RESUMEN

The heat treatment and seasoning of meat are indispensable before its consumption. In this work, the spectral characteristics of cooked meat and condiments were analysed by hyperspectral imaging (HSI) technology. The spectral reflectance of spices was significantly lower than that of meat protein, and that the spectral reflectance of protein regularly increased upon heating at 800-956 nm range. PCA pre-process and SVM models were used to predict beef moisture (R 2 = 0.912) and tenderness (R 2 = 0.771) based on 100 beef data. Mapping technology clearly showed the dynamic change of meat tenderness during heating, and the performance of 3D mapping was better than that of 2D mapping. Based on 750 nm/900 nm ratio image and machine-vision method, spice uniformity was accurately calculated. Thus, the quality of cooked meat and condiments distribution can be simultaneously evaluated by HSI. This technology can be used in the intelligent production of complex meat products in the future.

2.
Arch Pharm (Weinheim) ; 344(5): 320-32, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21509804

RESUMEN

Based on a novel lead compound 4-methylpiperazine-1-carbodithioic acid 3-cyano-3,3-diphenylpropyl ester 1, the systematic structural modification was carried out. All the synthesized compounds were evaluated for their in-vitro anticancer activities on four to six different cell lines at three different concentrations. Most of the tested compounds could selectively inhibit the growth of HL-60 and Bel-7402 cell lines at a medium concentration. Four compounds (3f, 3g, 3n, and 5) were selected for the IC(50) test, and the results revealed that three compounds (3g, 3n, and 5) showed almost the same or a slightly weaker activity than compound 1 against HL-60, and three compounds (3f, 3g, and 3n) showed >2-fold higher potency than compound 1 against Bel-7402. The in-vivo efficacy of 3n · HCl was evaluated with transplanted hepatocyte carcinoma 22 as an in-vivo test model. It was found that 3n · HCl could inhibit significantly the growth of tumor, and that this effect was dose-dependent. Meanwhile, the compound 3n · HCl showed low toxicity compared with compound 1 · HCl as evidenced by the little body-weight loss. These results confirmed that compound 3n · HCl is more potent than the lead compound 1 · HCl. Preliminary structure-activity relationships indicated that: a) Both nitrile group and the cyclic amine containing at least two nitrogens were indispensable moieties to keep the activity; b) substitution of the piperazine ring is unfavorable for the improvement of activity; c) the suitable linker joining the piperazinyl dithiocarboxyl and diphenylacetonitril group should be ethylene; d) a non-coplanar arrangement of the two benzene rings appears to be essential for activity.


Asunto(s)
Antineoplásicos/síntesis química , Tiocarbamatos/síntesis química , Tiocarbamatos/farmacología , Antineoplásicos/química , Antineoplásicos/farmacología , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Ésteres , Células HL-60 , Células HeLa , Humanos , Relación Estructura-Actividad , Tiocarbamatos/química
3.
Artículo en Inglés | MEDLINE | ID: mdl-18066870

RESUMEN

ANA975, a 5-amino-3-beta -D-ribofuranosyl-3H-thiazolo[4,5-d]pyrimidin-2-one derivative, was synthesized in the search of an oral prodrug of isatoribine, a small molecule toll-like receptor 7 (TLR-7) agonist. Several strategies were studied to enable the kilogram-scale synthesis of ANA975. Three general total syntheses are described. In the phase I clinical study of ANA975 against hepatitis C virus (HCV), conversion to isatoribine in plasma was rapid and effective, delivering levels of isatoribine that have been shown to be clinically relevant.


Asunto(s)
Diseño de Fármacos , Guanosina/análogos & derivados , Profármacos/administración & dosificación , Profármacos/síntesis química , Pirimidinonas/administración & dosificación , Pirimidinonas/síntesis química , Receptor Toll-Like 7/agonistas , Administración Oral , Antivirales/farmacología , Guanosina/farmacología , Humanos , Profármacos/química , Profármacos/farmacocinética , Pirimidinonas/química , Pirimidinonas/farmacocinética
4.
Bioorg Med Chem Lett ; 16(16): 4214-9, 2006 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-16766185

RESUMEN

A variety of 4-N atom substituted derivatives were synthesized and evaluated for their in vitro anticancer activities using 4-methylpiperazine-1-carbodithioic acid 3-cyano-3,3-diphenyl-propyl ester 4 as lead compound. Among them, compound 6a without any substituent on 4-N atom (R(1) = H) was found to be the most active anticancer agent with IC(50) = 5.3 microM against HL-60 and IC(50) = 11.5 microM against Bel-7402, respectively. Increase in the polarity and/or introduction of suitable acyl groups at the 4-N atom of the lead compound 4 are favorable for the improvement of activity.


Asunto(s)
Antineoplásicos/farmacología , Ditiocarba/química , Ditiocarba/farmacología , Antineoplásicos/síntesis química , Química Farmacéutica/métodos , Ditiocarba/síntesis química , Diseño de Fármacos , Ensayos de Selección de Medicamentos Antitumorales , Ésteres , Células HL-60 , Humanos , Concentración 50 Inhibidora , Modelos Químicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...